Targeting cytoskeletal assembly as a strategy to overcome taxane resistance in ovarian cancer

被引：0
|
作者：
Bennett, Marsha
Han, Liz Y.
Merritt, William
Lin, Yvonne
Gray, Joe W.
Gershenson, David M.
Sood, Anil K.
Schmandt, Rosemarie
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Lawrence Berkeley Natl Lab, Berkeley, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2007年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [21] Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer
    Rafaela Nasser Veiga
    Alexandre Luiz Korte de Azevedo
    Jaqueline Carvalho de Oliveira
    Daniela Fiori Gradia
    Journal of Molecular Medicine, 2024, 102 : 479 - 493
  • [22] Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer
    Martin, Sarah K.
    Kyprianou, Natasha
    ADVANCES IN CANCER RESEARCH, VOL 127, 2015, 127 : 123 - 158
  • [23] Photochemical Targeting of Mitochondria to Overcome Chemoresistance in Ovarian Cancer
    Rickard, Brittany P.
    Overchuk, Marta
    Obaid, Girgis
    Ruhi, Mustafa Kemal
    Demirci, Utkan
    Fenton, Suzanne E.
    Santos, Janine H.
    Kessel, David
    Rizvi, Imran
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2023, 99 (02) : 448 - 468
  • [24] A potential combinatorial treatment strategy to overcome olaparib resistance in high-grade ovarian cancer
    Bao, Jie
    Ortiz, Eva Daniela Mendoza
    Agudelo, Jessica
    Filimonov, Roman
    Farkkila, Anniina
    Tang, Jing
    CANCER RESEARCH, 2023, 83 (07)
  • [25] The Cytoskeletal Gateway of Survival and Drug Resistance in Ovarian Cancer
    Ferlini, Cristiano
    Mariani, Marisa
    Shahabi, Shohreh
    REPRODUCTIVE SCIENCES, 2011, 18 (03) : 289A - 290A
  • [26] Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies
    Wu, Wenda
    Xue, Xuezhen
    Chen, Yan
    Zheng, Ning
    Wang, Jichuang
    PHARMACOLOGICAL RESEARCH, 2022, 184
  • [27] Targeting nucleolin: A potential strategy to overcome stroma-mediated bevacizumab resistance in lung cancer
    Valerio-Fernandes, Angela
    Fonseca, Nuno
    Moura, Vera
    Ladeirinha, Ana
    Ferreira, Teresa
    Alarcao, Ana
    Carvalho, Lina
    Simoes, Sergio
    Moreira, Joao Nuno
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Survival following the documentation of platinum and taxane resistance in ovarian cancer
    Büyükçelik, A
    Yalçin, M
    Utkan, G
    Doruk, H
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 774 - 775
  • [29] EP-100+paclitaxel to overcome taxane resistance in patients with recurrent LHRH-receptor expressing ovarian cancer.
    Nick, Alpa Manchandia
    Urban, Renata
    Gordinier, Mary E.
    Leuschner, Carola
    Rado, Thomas
    Bavisotto, Linda M.
    Whisnant, John
    Coleman, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] New strategies to overcome platinum resistance in ovarian cancer
    Wei, Jian-Jun
    Martinelli, Fabio
    FRONTIERS IN ONCOLOGY, 2024, 14
12345